Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Classical hematology 1

Conditions

Venous Thromboembolism 2Thrombocytopenia 2Hematologic Neoplasms 2Disease 2Anemia, Sickle Cell 2Anemia 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1VLCAD deficiency 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1Usher syndrome, type 1B 1Tyrosinemias 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Trifunctional Protein Deficiency With Myopathy And Neuropathy 1Thyroid Dyshormonogenesis 6 1Thyroid Dyshormonogenesis 5 1Thyroid Dyshormonogenesis 3 1Thyroid Dyshormonogenesis 2A 1Thyroid Dyshormonogenesis 1 1Stress Disorders, Post-Traumatic 1Stickler syndrome, type 2 1Stickler syndrome, type 1 1

Interventions

Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Bone Neoplasms × Classical hematology × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡